Related references
Note: Only part of the references are listed.Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Rituximab for the Treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia
Fredrick Hagemeister
DRUGS (2010)
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Paul A. Blair et al.
IMMUNITY (2010)
Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders
M. C. Levesque
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Rituximab-induced vasculitis: A case report and review of the medical published work
Min Joo Kim et al.
JOURNAL OF DERMATOLOGY (2009)
Selective Targeting of B Cells with Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/lpr Mice
Paul A. Blair et al.
JOURNAL OF IMMUNOLOGY (2009)
OPINION B-cell-depletion therapy in SLE-what are the current prospects for its acceptance?
Catarina Favas et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
B-Cell-Depleting Induction Therapy and Acute Cellular Rejection
Menna R. Clatworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Rituximab-Induced Hypersensitivity Pneumonitis
Adriano R. Tonelli et al.
RESPIRATION (2009)
Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus
K. Suzuki et al.
RHEUMATOLOGY (2009)
The who, how and where of antigen presentation to B cells
Facundo D. Batista et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma
F. Mielke et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Rituximab efficacy and. safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:: results of a prospective multicenter phase 2 study
Bertrand Godeau et al.
BLOOD (2008)
Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients
G. J. Silverman et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenstrom's macroglobulinemia
Aisha Shaikh et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2008)
Cytokine-producing B lymphocytes - key regulators of immunity
Frances E. Lund
CURRENT OPINION IN IMMUNOLOGY (2008)
B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes
Gillian M. Brodie et al.
DIABETES (2008)
Rituximab in relapsing Graves' disease, a phase II study
Karen A. Heemstra et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses
Koichi Yanaba et al.
IMMUNITY (2008)
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Takashi Matsushita et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
B Lymphocytes Promote Expansion of Regulatory T Cells in Oral Tolerance: Powerful Induction by Antigen Coupled to Cholera Toxin B Subunit
Jia-Bin Sun et al.
JOURNAL OF IMMUNOLOGY (2008)
TLR-activated B cells suppress T cell-mediated autoimmunity
Vicky Lampropoulou et al.
JOURNAL OF IMMUNOLOGY (2008)
B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models
Samuel Kim et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma
Xin Liu et al.
LEUKEMIA & LYMPHOMA (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Not always the bad guys: B cells as regulators of autoimmune pathology
Simon Fillatreau et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia
Claire Dearden et al.
BLOOD (2008)
Exacerbation of ulcerative colitis after rituximab salvage therapy
Martin Goetz et al.
INFLAMMATORY BOWEL DISEASES (2007)
Rituximab-induced interstitial lung disease
Stephanie A. Wagner et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells
M. Gray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A single cycle of rituximab for the treatment of severe pemphigus
Pascal Joly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Development of psoriasis after B cell depletion with rituximab
Shouvik Dass et al.
ARTHRITIS AND RHEUMATISM (2007)
Novel suppressive function of transitional 2 B cells in experimental arthritis
Jamie G. Evans et al.
JOURNAL OF IMMUNOLOGY (2007)
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
Martin Duddy et al.
JOURNAL OF IMMUNOLOGY (2007)
Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin
A. Razzaque Ahmed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Lymphoid neogenesis in chronic rejection: the murderer is in the house
Olivier Thaunat et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
The emerging role of rituximab in organ transplantation
Yolanda T. Becker et al.
TRANSPLANT INTERNATIONAL (2006)
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia
Giovanni D'Arena et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
B-cell targeting in rheumatoid arthritis and other autoimmune diseases
JCW Edwards et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Autoimmune complications of chronic lymphocytic leukemia
TJ Hamblin
SEMINARS IN ONCOLOGY (2006)
Lymphoid organ development: from ontogeny to neogenesis
DL Drayton et al.
NATURE IMMUNOLOGY (2006)
Primary T cell expansion and requires antigen presentation differentiation in vivo by B cells
Alison Crawford et al.
JOURNAL OF IMMUNOLOGY (2006)
Lymphoid neogenesis in chronic inflammatory diseases
F Aloisi et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Rituximab-induced Leukocytoclastic vasculitis: A case report
P Kandula et al.
ARCHIVES OF DERMATOLOGY (2006)
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients
MJ Leandro et al.
RHEUMATOLOGY (2005)
Lymphoid neogenesis in chronic rejection: Evidence for a local humoral alloimmune response
O Thaunat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Antibody-mediated organ-allograft rejection
RB Colvin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS 13-deficient thrombotic thrombocytopenic purpura:: a study of 11 cases
F Fakhouri et al.
BLOOD (2005)
Rituximab treatment in patients with primary Sjogren's syndrome
J Pijpe et al.
ARTHRITIS AND RHEUMATISM (2005)
Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets
B Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy
Q Gong et al.
JOURNAL OF IMMUNOLOGY (2005)
TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production
P Lenert et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2005)
B cell depletion as a novel treatment for systemic lupus erythematosus - A phase I/II dose-escalation trial of rituximab
RJ Looney et al.
ARTHRITIS AND RHEUMATISM (2004)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Rituximab as treatment for refractory kidney transplant rejection
YT Becker et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Efficacy and safety of rituximab in type II mixed cryoglobulinemia
F Zaja et al.
BLOOD (2003)
Prevention of arthritis by interleukin 10-producing B cells
C Mauri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Severe autoimmune hemolytic anemia following rituximab therapy in a patient with a lymphoproliferative disorder
E Jourdan et al.
LEUKEMIA & LYMPHOMA (2003)
Rituximab in the treatment of acquired factor VIII inhibitors
A Wiestner et al.
BLOOD (2002)
B cells regulate autoimmunity by provision of IL-10
S Fillatreau et al.
NATURE IMMUNOLOGY (2002)
T cell activation in rheumatoid synovium is B cell dependent
S Takemura et al.
JOURNAL OF IMMUNOLOGY (2001)
B cells acquire antigen from target cells after synapse formation
FD Batista et al.
NATURE (2001)
Rituximab: A very efficient therapy in cold agglutinins and refractory autoimmune haematolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma.
F Bauduer
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Completeness of safety reporting in randomized trials - An evaluation of 7 medical areas
JPA Ioannidis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
A critical role for B cells in the development of memory CD4 cells
PJ Linton et al.
JOURNAL OF IMMUNOLOGY (2000)
Rituximab for myasthenia gravis developing after bone marrow transplant
F Zaja et al.
NEUROLOGY (2000)
B lymphocytes regulate dendritic cell (DC) function in vivo: Increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation
V Moulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
